GlassScriptPhysician profile
Jeffrey D Reich
NPI 1942265020
$6,991.35
in general payments reported to CMS, 2019-2025
41 companies · $1,824 in 2025
The $1,824 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $401 · 2021: $211 · 2022: $434 · 2023: $2,264 · 2024: $1,162 · 2025: $1,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,190 · Travel and Lodging: $1,005 · Education: $39.91 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,189.67 |
| Travel and Lodging | $1,004.74 |
| Education | $39.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,519.83 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $787.05 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $656.43 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $646.32 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $595.32 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Ferring Pharmaceuticals INC. | $262.31 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $257.85 | 2019-2025 | |
| Abbvie INC. | $228.47 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $188.86 | 2022-2025 | Pylarify |
| Immunitybio, INC. | $179.23 | 2025 | |
| Pfizer INC. | $163.82 | 2022-2025 | |
| Endo USA, INC. | $144.82 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $125.85 | 2022-2025 | |
| Boston Scientific Corporation | $122.90 | 2019-2025 | Rezum Generator, Ams 700 |
| Endo Pharmaceuticals INC. | $94.25 | 2019-2023 | Xiaflex |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $90.95 | 2024-2025 | Interstim |
| Telix Pharmaceuticals | $90.66 | 2023-2025 | Illuccix |
| Novartis Pharmaceuticals Corporation | $78.34 | 2024-2025 | |
| Mission Pharmacal Company | $71.28 | 2022-2023 | Uribel |
| Teleflex LLC | $62.97 | 2022-2025 | Urolift |
| Myriad Genetic Laboratories, INC. | $60.85 | 2020-2022 | |
| Urovant Sciences INC | $49.22 | 2022 | |
| Merck Sharp & Dohme LLC | $46.52 | 2022-2023 | Lynparza, Keytruda |
| Coloplast Corp | $45.84 | 2022-2025 | |
| Axonics, INC. | $44.19 | 2023-2024 | Axonics |
| Convatec INC. | $37.76 | 2022 | |
| Allergan, INC. | $36.48 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Laborie Medical Technologies Corp. | $33.92 | 2023 | |
| Olympus America INC. | $25.75 | 2025 | Itind System |
| Myovant Sciences INC. | $25.56 | 2021 | |
| Azurity Pharmaceuticals, INC. | $24.99 | 2025 | Azmiro |
| 180 Medical, INC. | $24.05 | 2019 | |
| Amgen INC. | $23.87 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $20.13 | 2019 | |
| Profound Medical Corp. | $17.46 | 2025 | Tulsa-Pro |
| Tolmar, INC. | $15.25 | 2023 | |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
| Conmed Corporation | $14.20 | 2022 | |
| Dentsply Ih INC. | $13.89 | 2019 | |
| Verity Pharmaceuticals INC. | $13.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Reich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.